Related Experiment Video
Updated: Feb 13, 2026

An Ex vivo Model to Study Hormone Action in the Human Breast
Published on: January 8, 2015
Heart Disease and Relaxin: New Actions for an Old Hormone
Teja Devarakonda1, Fadi N Salloum1
1Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298-0204, USA.
Abstract:
The hormone relaxin has long been recognized for its involvement in maternal adaptation during pregnancy. However, discoveries during the past two decades on the mechanism of action of relaxin, its family of receptors, and newly described roles in attenuating ischemia/reperfusion (I/R) injury, inflammation, and arrhythmias have prompted vast interest in exploring its therapeutic potential in cardiovascular disease. These observations inspired recently concluded clinical trials in patients with acute heart failure. This review discusses our current understanding of the protective signaling pathways elicited by relaxin in the heart, and highlights important new breakthroughs about relaxin signaling that may pave the way to more carefully designed future trials.
Related Concept Videos
Secondary Messengers in Hormone Action
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
Types of Hormones
Hormonal Regulation
Hormonal Regulation
Plant Hormones
Rheumatic Heart Disease I: Introduction

